Bedside Glucose Monitoring—Is it Safe? A New, Regulatory-Compliant Risk Assessment Evaluation Protocol in Critically Ill Patient Care Settings*

OBJECTIVES: New data have emerged from ambulatory and acute care settings about adverse patient events, including death, attributable to erroneous blood glucose meter measurements and leading to questions over their use in critically ill patients. The U.S. Food and Drug Administration published new,...

Descripción completa

Detalles Bibliográficos
Autores principales: DuBois, Jeffrey Anton, Slingerland, Robbert Jan, Fokkert, Marion, Roman, Alain, Tran, Nam Khoa, Clarke, William, Sartori, David Alan, Palmieri, Tina Louise, Malic, Andrei, Lyon, Martha Elizabeth, Lyon, Andrew William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345889/
https://www.ncbi.nlm.nih.gov/pubmed/28169943
http://dx.doi.org/10.1097/CCM.0000000000002252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345889/
https://www.ncbi.nlm.nih.gov/pubmed/28169943
http://dx.doi.org/10.1097/CCM.0000000000002252

Ejemplares similares